Total Payments
$13,480
2024 Payments
$2,128
Companies
18
Transactions
98
Medicare Patients
1,823
Medicare Billing
$146,891
Payment Breakdown by Category
Research$9,200 (68.2%)
Food & Beverage$2,137 (15.9%)
Consulting$2,128 (15.8%)
Education$15.27 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $9,200 | 4 | 68.2% |
| Food and Beverage | $2,137 | 92 | 15.9% |
| Consulting Fee | $2,128 | 1 | 15.8% |
| Education | $15.27 | 1 | 0.1% |
Payments by Type
Research
$9,200
4 transactions
General
$4,280
94 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $9,467 | 13 | $0 (2023) |
| GENZYME CORPORATION | $2,174 | 3 | $0 (2024) |
| ABBVIE INC. | $546.13 | 36 | $0 (2022) |
| Sun Pharmaceutical Industries Inc. | $301.90 | 13 | $0 (2022) |
| Galderma Laboratories, L.P. | $273.58 | 3 | $0 (2018) |
| Regeneron Healthcare Solutions, Inc. | $176.04 | 3 | $0 (2022) |
| Allergan, Inc. | $165.05 | 7 | $0 (2022) |
| LEO Pharma Inc. | $94.08 | 7 | $0 (2022) |
| Lilly USA, LLC | $49.52 | 2 | $0 (2022) |
| UCB, Inc. | $34.90 | 2 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,128 | 1 | GENZYME CORPORATION ($2,128) |
| 2023 | $15.27 | 1 | PFIZER INC. ($15.27) |
| 2022 | $9,930 | 41 | PFIZER INC. ($9,376) |
| 2021 | $873.54 | 46 | AbbVie Inc. ($293.72) |
| 2019 | $48.44 | 2 | AbbVie, Inc. ($48.44) |
| 2018 | $485.06 | 7 | Galderma Laboratories, L.P. ($273.58) |
All Payment Transactions
98 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/18/2024 | GENZYME CORPORATION | — | Consulting Fee | Cash or cash equivalent | $2,128.00 | General |
| 04/20/2023 | PFIZER INC. | CIBINQO (Drug) | Education | In-kind items and services | $15.27 | General |
| Category: Inflammation & Immunology | ||||||
| 07/01/2022 | Sun Pharmaceutical Industries Inc. | Odomzo (Drug), BLU-U | Food and Beverage | In-kind items and services | $23.19 | General |
| Category: Oncology | ||||||
| 06/28/2022 | Sun Pharmaceutical Industries Inc. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $19.08 | General |
| Category: Dermatology | ||||||
| 06/16/2022 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $26.43 | General |
| Category: IMMUNOLOGY | ||||||
| 06/08/2022 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $29.01 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 06/05/2022 | PFIZER INC. | CIBINQO (Drug) | Food and Beverage | In-kind items and services | $120.00 | General |
| Category: Inflammation & Immunology | ||||||
| 05/31/2022 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $13.11 | General |
| Category: DERMATOLOGY | ||||||
| 05/26/2022 | PFIZER INC. | EUCRISA (Drug), CIBINQO | Food and Beverage | In-kind items and services | $16.65 | General |
| Category: DERMATOLOGY | ||||||
| 05/25/2022 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $17.15 | General |
| Category: IMMUNOLOGY | ||||||
| 05/18/2022 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $4.70 | General |
| Category: IMMUNOLOGY | ||||||
| 05/13/2022 | Almirall LLC | Seysara (Drug) | Food and Beverage | Cash or cash equivalent | $16.70 | General |
| Category: Dermatology | ||||||
| 05/12/2022 | PFIZER INC. | CIBINQO (Drug) | — | In-kind items and services | $1,400.00 | Research |
| Study: ABROCITINIB CLINICAL PUBLICATION PROGRAM • Category: Inflammation & Immunology | ||||||
| 05/03/2022 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $20.75 | General |
| Category: IMMUNOLOGY | ||||||
| 04/27/2022 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $4.90 | General |
| Category: IMMUNOLOGY | ||||||
| 04/26/2022 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $12.24 | General |
| Category: DERMATOLOGY | ||||||
| 04/15/2022 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $14.89 | General |
| Category: DERMATOLOGY | ||||||
| 04/12/2022 | Allergan, Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $26.50 | General |
| Category: FACIAL AESTHETICS | ||||||
| 04/05/2022 | Sun Pharmaceutical Industries Inc. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $17.92 | General |
| Category: Dermatology | ||||||
| 03/31/2022 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $15.91 | General |
| Category: Dermatology | ||||||
| 03/31/2022 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $6.89 | General |
| Category: IMMUNOLOGY | ||||||
| 03/23/2022 | PFIZER INC. | EUCRISA (Drug), CIBINQO | Food and Beverage | In-kind items and services | $24.11 | General |
| Category: DERMATOLOGY | ||||||
| 03/23/2022 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $5.30 | General |
| Category: IMMUNOLOGY | ||||||
| 03/22/2022 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $12.44 | General |
| Category: DERMATOLOGY | ||||||
| 03/16/2022 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $17.62 | General |
| Category: IMMUNOLOGY | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| ABROCITINIB CLINICAL PUBLICATION PROGRAM | PFIZER INC. | $9,200 | 4 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 531 | 1,015 | $237,135 | $50,083 |
| 2022 | 12 | 680 | 1,123 | $234,466 | $47,390 |
| 2021 | 12 | 612 | 1,000 | $211,175 | $49,418 |
Total Patients
1,823
Total Services
3,138
Medicare Billing
$146,891
Procedure Codes
36
All Medicare Procedures & Services
36 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 95 | 130 | $44,850 | $10,007 | 22.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 51 | 73 | $31,244 | $7,227 | 23.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 74 | 104 | $31,512 | $6,653 | 21.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 44 | 44 | $24,552 | $4,887 | 19.9% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 38 | 100 | $17,100 | $4,156 | 24.3% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 70 | 103 | $23,381 | $3,590 | 15.4% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2023 | 12 | 14 | $14,448 | $3,084 | 21.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 45 | 45 | $16,920 | $3,047 | 18.0% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 25 | 31 | $11,935 | $2,610 | 21.9% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 53 | 344 | $7,912 | $1,844 | 23.3% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 11 | 12 | $6,876 | $1,566 | 22.8% |
| 11104 | Punch biopsy, first skin growth | Office | 2023 | 13 | 15 | $6,405 | $1,412 | 22.0% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 117 | 130 | $44,248 | $9,076 | 20.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 100 | 121 | $35,767 | $6,875 | 19.2% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2022 | 60 | 130 | $22,123 | $5,415 | 24.5% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2022 | 35 | 36 | $20,043 | $4,900 | 24.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 50 | 55 | $22,976 | $4,027 | 17.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 52 | 52 | $19,204 | $3,870 | 20.2% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 97 | 114 | $25,298 | $3,673 | 14.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 27 | 27 | $14,837 | $3,368 | 22.7% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 30 | 31 | $11,657 | $2,253 | 19.3% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 82 | 395 | $9,085 | $2,096 | 23.1% |
| 11104 | Punch biopsy, first skin growth | Office | 2022 | 14 | 14 | $5,912 | $1,144 | 19.3% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 16 | 18 | $3,316 | $694.91 | 21.0% |
| 11102 | Tangential biopsy of single skin lesion | Office | 2021 | 82 | 94 | $31,584 | $7,088 | 22.4% |
About Dr. Natalie Yin, MD
Dr. Natalie Yin, MD is a Procedural Dermatology healthcare provider based in Hillsboro, Oregon. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/05/2014. The National Provider Identifier (NPI) number assigned to this provider is 1215340450.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Natalie Yin, MD has received a total of $13,480 in payments from pharmaceutical and medical device companies, with $2,128 received in 2024. These payments were reported across 98 transactions from 18 companies. The most common payment nature is "" ($9,200).
As a Medicare-enrolled provider, Yin has provided services to 1,823 Medicare beneficiaries, totaling 3,138 services with total Medicare billing of $146,891. Data is available for 3 years (2021–2023), covering 36 distinct procedure/service records.
Ad
Practice Information
- Specialty Procedural Dermatology
- Other Specialties Dermatology
- Location Hillsboro, OR
- Active Since 06/05/2014
- Last Updated 06/18/2023
- Taxonomy Code 207NS0135X
- Entity Type Individual
- NPI Number 1215340450
Products in Payments
- CIBINQO (Drug) $9,335
- SKYRIZI (Biological) $343.27
- Ilumya (Biological) $174.22
- EUCRISA (Drug) $132.05
- DUPIXENT DUPILUMAB INJECTION (Biological) $121.80
- DUPIXENT (Biological) $99.98
- RINVOQ (Biological) $78.56
- HUMIRA (Biological) $75.86
- ADBRY (Biological) $65.37
- ILUMYA (Biological) $50.47
- BOTOX (Biological) $49.87
- TALTZ (Drug) $49.52
- Skyrizi (Biological) $48.44
- BLU-U (Medical Supply) $42.28
- Cimzia (Drug) $34.90
- RHOFADE (Drug) $34.38
- OPZELURA (Drug) $33.43
- IMLYGIC (Biological) $31.72
- ENSTILAR (Drug) $28.71
- AMZEEQ (Drug) $28.00
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.